Document Type
Article
Department
Radiation Oncology; Paediatrics and Child Health; Pathology and Laboratory Medicine
Abstract
Objective: To assess the knowledge and attitude of Muslim cancer patients regarding cancer treatment during Ramadan.
Methods: This cross-sectional study was conducted at the Aga Khan University Hospital, Karachi, from July to August 2015, and comprised cancer patients. .Adult Muslim cancer patients receiving active oncological treatment or on surveillance were included. Patients on only supportive treatment were excluded. SPSS 19 was used for data analysis.
Results: Of the 265 patients, 87(32.8%) were males and 178(67.2%) were females. The overall mean age was 49±13.87 years. Besides, 184(70.9%) patients belonged to the middle class. Breast cancer was the most common cancer 106(40.6%). Overall, 153(57.9%) patients had stage II disease. Further, 201(80%) patients had 0-1 performance status. Moreover, 180(72%) patients were receiving different forms of chemotherapeutic agents. It was found that 113(54.3%) patients sought advice regarding fasting. Most of the patients who observed fast, i.e. 214(81%), had an early stage disease and 19(7.1%) were on hormonal therapy. Patients who did not fast mostly attributed this to fatigue 69(26.3%). Conclusion: Only half of the patients sought advice on fasting and those having early disease more.
Conclusions: Only half of the patients sought advice on fasting and those having early disease more frequently observed fast.
Publication (Name of Journal)
JPMA. The Journal of the Pakistan Medical Association
Recommended Citation
Rasheed, A. A.,
Rashid, Y. A.,
Pirzada, F. T.,
Haroon, F.,
Jabbar, A.,
Buksh, A. R.
(2017). Knowledge, attitude and perceptions of Muslim cancer patients regarding cancer treatment during Ramadan: Results from a tertiary care hospital Karachi. JPMA. The Journal of the Pakistan Medical Association, 67(8), 1144-1150.
Available at:
https://ecommons.aku.edu/pakistan_fhs_mc_radiat_oncol/58
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Included in
Oncology Commons, Pathology Commons, Radiation Medicine Commons